← Eichor
Study identifier: NCT05181748 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders

Condition: Poor Response to Ovulation Induction · Infertility, Female · Ovarian Insufficiency  ·  Sponsor: Genesis Athens Clinic

PhasePhase 2/Phase 3
Planned participants100
Who can joinFemale, 35 Years to 47 Years
Healthy volunteersYes

About this study

Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subjected to intracytoplasmic sperm injection (ICSI) treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Agni Pantou, M.D  ·  +306974447702  ·  agni.pantou@genesisathens.gr

Konstantinos Pantos, M.D., Ph.D  ·  +302106894326  ·  info@pantos.gr

Always discuss trial participation with your own doctor first.

Locations (1)

Genesis Athens ClinicAthens, Attica, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05181748